PanX, a new medication collection meant to treat anxiety disorders, has been patented and TPD LLC will oversee clinical development and commercialization efforts.
PanX is a non-addictive drug meant to be taken as it’s needed, the company said in a statement. Its ingredients include beta blockers, which interfere with adrenaline and address heart palpitations associated with anxiety, and antiemetic antimuscarinic agents, which are commonly used to treat feelings of motion sickness that stem from the central nervous system.
The drug, invented by Thomas P. Dooley, PhD, is currently available as prescription compounded pharmaceuticals, but TPD is also seeking approval from the U.S. Food and Drug Administration for some of its products.
The medication is fast-acting, so it can benefit patients who find themselves suddenly suffering from a panic attack or anxiety at random moments.
"A number of patients with prominent anxiety symptoms do not respond or cannot tolerate currently available treatments,” said Charles B. Nemeroff, MD, PhD, the chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami, in a statement. “This novel approach combining two medications with distinct mechanisms of action has the potential to fill an important niche in the management of such patients."
Senior Writer
As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.